XML 23 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:      
Net income $ 280,301 $ 254,223 $ 438,324
Adjustments to reconcile net income to net cash provided by operating activities:      
Deferred income tax benefit 20,470 (3,446) (71,068)
Provision for bad debts, net 7,264 6,429 3,718
Unrealized (gains)/losses on investment securities (876) 3,680 4,228
Non-cash lease expense 32,908 26,609 31,508
Depreciation and amortization 28,536 58,221 48,537
Contingent consideration valuation (10,373) 2,131 7,104
Compensation expense — equity and liability classified share awards (Note 14) 166,595 156,936 91,875
Changes in operating assets and liabilities:      
Accounts receivable (23,828) (37,742) 14,128
Unbilled work in progress (77,477) (11,596) 18,036
Other assets (6,756) (25,958) 14,895
Accrued salaries and bonuses (42,269) (189,534) 150,721
Accounts payable and accrued expenses and other (23,192) (32,014) (9,955)
Deferred income 7,556 (11,943) (807)
Income taxes payable (15,289) (83,609) (6,254)
Net cash provided by operating activities 328,458 136,273 736,604
Cash flows from investing activities:      
Purchases of investment securities (11,278) (19,230) (101,562)
Sales or maturities of investment securities 11,458 87,384 197,324
Acquisition of business, net of cash acquired (3,856) (20,427) (360,996)
Purchase of property and equipment, net (66,730) (50,731) (8,680)
Net cash used in investing activities (70,406) (3,004) (273,914)
Cash flows from financing activities:      
Dividends paid (148,454) (140,384) (114,806)
Share repurchases (24,952) (48,659) (304,793)
Payments to settle employee tax obligations on share-based awards (70,713) (42,283) (33,741)
Earnouts paid (7,053) (6,679) (5,917)
Loans payable to former shareholders redeemed 0 (539) (280)
Repayments of loans to non-affiliates 0 (2,488) 0
Other financing activities 587 570 477
Net cash used in financing activities (250,585) (240,462) (459,060)
Effects of exchange rate changes on cash and cash equivalents (425) (12,065) (16,784)
Net increase/(decrease) in cash, cash equivalents, and restricted cash 7,042 (119,258) (13,154)
Cash, cash equivalents and restricted cash – beginning of period 714,812 834,070 847,224
Cash, cash equivalents and restricted cash – end of period 721,854 714,812 834,070
Supplemental disclosures of non-cash activities:      
Shares issued via vesting of liability classified awards 5,176 5,955 4,270
Promissory note issued as consideration for acquisition 14,500 0 0
Shares issued as consideration for acquisition 19,343 7,238 2,000
Cash acquired through acquisitions 224 11,933 244,162
Cash paid during the year:      
Interest 579 5,904 1,000
Taxes, net of refunds 105,056 156,786 242,031
Regulatory fines and penalties $ 15,000 $ 0 $ 0